65,437 trials
Constipation · Chronic Constipation
Primary: Change From Baseline in Frequency of Spontaneous Bowel Movements — 2.5; 4.0; 5.4; 1.7 Number of SBMs — p=<0.2
Flat Foot · Pressure Ulcer
Primary: Heel Pressure Sores (Numbers of Participants With Heel Pressure Sores) — 17; 21 Participants
Unresectable or Metastatic Melanoma
Primary: Objective Response Rate (ORR) — 27.2; 9.8 Percentage of participants
Malaria
Primary: Change in Percentage of Parasites Detected at 48 Hours — 99.998 percentage of parasite change
Aspirin Exacerbated Respiratory Disease (AERD)
Primary: Proportion of Patients Who Experience a ≥ 20% Decrease in Forced Expiratory Volume in One Second (FEV1) Compared to Baseline Following a Dose of Investigational…
Schizophrenia
Primary: Change From Baseline in the Positive and Negative Syndrome Scale (PANSS) Total Score at Week 6. — 94.5; 94.0; 92.8; -18.6 units on a scale — p=0.0003
Cocaine Dependence
Primary: Visual Analog Scale Subjective Rating of Drug Effects — 8.65; 9.85; 13.65; 10.43 units on a scale
Postoperative Pain
Primary: Average Postoperative Pain Score — 6.0; 7.3 units on a scale — p=0.0241
Atrial Fibrillation
Primary: Passive Emptying of Left Atrium — 14.7; 20.9 cm
Infections After Lung Transplant
Primary: The Primary Outcome Will be the Total Number of Days With Pneumonia. — 1714; 51 Number of days
HIV Infections
Primary: Change From Baseline to 24 Weeks in HIV DNA (Log-10 Copies/10^6 Cells) as Measured by HIV DNA Within CD14+ Peripheral Blood Mononuclear Cells — 0.58 Log-10 copies/10^6…
Cryptosporidium; Diarrhea · Cryptosporidiosis · Communicable Diseases
Primary: Longitudinal Diarrhea Prevalence — 7.6; 8.9 Incidence rate per 100 person-weeks
Occupational Radiation Exposure
Primary: Effective Radiation Dose — 0.0307; 0.0192 mSv
Gastric Bypass · Parathyroid Hormone
Primary: The Primary Outcome Measure With iPTH — 72; 87; 82 pg/mL
Metastatic Renal Cell Carcinoma
Primary: Number of Subjects With Treatment-emergent Adverse Events — 3; 3; 6; 3 participants